Delivery Order SPE2DB20D1110-SPE2DB25FK28V
- Not listed
- The Defense Logistics Agency awarded a $15,976.54 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, carries a firm fixed price and is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,450.73 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count package) on July 29, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded without set-aside designation, with performance taking...
- The Defense Logistics Agency awarded a delivery order valued at $9,071.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) valued at $1,299.04 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This contract utilizes no set-aside designation and reflects competitive procurement practices....
- The Defense Logistics Agency awarded a delivery order valued at $34,989.37 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded contract—issued on August 13, 2025, with an ultimate completion date of August 14, 2025—represents a pharmaceutical delivery supporting federal medical procurement requirements. The contract has no set-aside designation and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,022.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, non-set-aside contract issued under a competitively awarded vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,696.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $7,644.87 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK28VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,889.67 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8s on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The NURTEC ODT delivery under this order supports the broader pharmaceutical supply chain for federal defense and military medical programs, consistent with DLA's mission to provide medical materiel and supply chain support across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/23/25 |